Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have earned an average rating of “Hold” from the ten brokerages that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $63.14.

A number of research analysts have commented on the stock. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday, November 14th.

Shares of Nu Skin Enterprises (NUS) traded up $0.71 during mid-day trading on Tuesday, reaching $68.67. 334,400 shares of the company’s stock traded hands, compared to its average volume of 313,744. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18. Nu Skin Enterprises has a 52 week low of $47.10 and a 52 week high of $70.27. The stock has a market cap of $3,615.48, a PE ratio of 25.15, a PEG ratio of 2.24 and a beta of 1.56.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.76. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business had revenue of $563.70 million for the quarter, compared to analyst estimates of $562.70 million. During the same period last year, the business earned $0.98 EPS. The company’s revenue was down 6.7% on a year-over-year basis. sell-side analysts predict that Nu Skin Enterprises will post 3.23 earnings per share for the current fiscal year.

In related news, President Ryan S. Napierski sold 11,667 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $63.84, for a total transaction of $744,821.28. Following the completion of the transaction, the president now owns 71,634 shares of the company’s stock, valued at $4,573,114.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Steven Lund sold 108,132 shares of the company’s stock in a transaction that occurred on Friday, December 22nd. The stock was sold at an average price of $68.81, for a total transaction of $7,440,562.92. Following the transaction, the chairman now directly owns 4,769 shares of the company’s stock, valued at approximately $328,154.89. The disclosure for this sale can be found here. In the last three months, insiders sold 220,776 shares of company stock valued at $14,784,324. Company insiders own 5.20% of the company’s stock.

A number of hedge funds have recently modified their holdings of NUS. BlackRock Inc. grew its stake in Nu Skin Enterprises by 1.8% during the second quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock worth $427,632,000 after buying an additional 121,562 shares during the period. Vanguard Group Inc. boosted its stake in shares of Nu Skin Enterprises by 0.8% in the second quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock valued at $380,838,000 after purchasing an additional 48,805 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Nu Skin Enterprises by 5.0% in the third quarter. JPMorgan Chase & Co. now owns 1,416,305 shares of the company’s stock valued at $87,443,000 after purchasing an additional 66,986 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Nu Skin Enterprises by 5.4% in the third quarter. Dimensional Fund Advisors LP now owns 1,125,625 shares of the company’s stock valued at $69,204,000 after purchasing an additional 57,750 shares during the period. Finally, Wasatch Advisors Inc. boosted its stake in shares of Nu Skin Enterprises by 0.3% in the third quarter. Wasatch Advisors Inc. now owns 640,595 shares of the company’s stock valued at $39,384,000 after purchasing an additional 2,199 shares during the period. 77.50% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2018/01/16/nu-skin-enterprises-inc-nus-receives-average-rating-of-hold-from-analysts.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.